New estimates suggest that mass gatherings during an election in the Malaysian state of Sabah directly caused 70 percent of COVID-19 cases detected in Sabah after the election, and indirectly caused 64.4 percent of cases elsewhere in Malaysia. Jue Tao Lim of the National University of Singapore, Kenwin Maung of the University of Rochester, New York, and colleagues present these findings in the open-access journal PLOS Computational Biology.
SingHealth Duke-NUS Academic Medical Centre and Cordlife partner to advance stem cell technology to first-in-man clinical trial in Singapore asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Upon collection after the delivery of a baby, cord blood is processed to extract stem cells and to prepare it for long-term cryopreservation view more
Credit: Cordlife Group Limited
SINGAPORE, 11 May 2021 - Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore s first private cord blood bank, Cordlife Group Limited (Cordlife), to test a novel technology that expands the number of blood-forming stem cells from stored umbilical cord blood (UCB) in a first-in-man study in Singapore. This is the first time a home-grown UCB cell therapy is being tested on humans. The technology has the potential to increase treatment options for patients suffering from blood cancers or blood-related conditions.
The Straits Times
This needs to be addressed as risk factors are linked to lifestyle, dietary habits: Researcher
A man taking a diabetes test at an event earlier this month. A study found that almost half of the respondents - 44.8 per cent - said they did not know where to get free diabetes screening.ST PHOTO: CHONG JUN LIANG
https://str.sg/JFkE
They can read the article in full after signing up for a free account.
Share link:
Or share via:
Sign up or log in to read this article in full
Sign up
All done! This article is now fully available for you
Date Time
Researchers Identify Potential Targets for Novel Treatments for Lung Cancer
Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor-related deaths. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease.
A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology in the laboratory of Daniel Tenen MD, at Beth Israel Deaconess Medical Center (BIDMC), evaluated a novel agent, PTC596, capable of decreasing tumor growth in preclinical studies performed on a mouse model of mutant K-RAS lung cancer. The research – performed in collaboration with the Cancer Science Institute of Singapore at the National University of Singapore (CSI NUS) – were published today in the journal Communications Biology. The findings, which represent a comprehensive snapshot of the tumor’s components, will facilitate the d